Clifford J Whelan

Title: The Innovations of Clifford J. Whelan

Introduction

Clifford J. Whelan, an accomplished inventor based in Buntingford, GB, has made significant contributions to the field of medicine through his innovative patents. With a focus on the treatment of inflammation and allergies, his work at Glaxo Group Limited has positioned him as a notable figure in pharmaceutical advancements.

Latest Patents

Whelan holds two patents that underscore his commitment to improving human health. His first patent addresses a new medical use for the phenethanolamine compound 4-hydroxy-.alpha.-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-1,3-benzenedimethanol, along with its physiologically acceptable salts and solvates. This invention aims to effectively treat inflammation, allergies, and allergic reactions. The second patent focuses on a compound for similar uses: the dichloroaniline 4-amino-3,5-dichloro-.alpha.-[[[6-[2-(2-pyridinyl)ethoxy]hexyl]amino]methy l]benzenemethanol and its enantiomers, which serve as a new medical approach for the same health issues.

Career Highlights

Throughout his career, Whelan has remained dedicated to developing innovative solutions that enhance therapeutic options for patients. His work at Glaxo Group Limited has not only fostered his growth as an inventor but also contributed to the company’s portfolio of groundbreaking medical advancements.

Collaborations

Collaborating with fellow researcher Malcolm Johnson, Whelan has combined expertise and resources to push the boundaries of medical research. Their partnership has led to significant advancements in the treatment strategies for inflammation and allergies.

Conclusion

Clifford J. Whelan's commitment to innovation is evident through his patents and collaborations in the pharmaceutical industry. His contributions at Glaxo Group Limited serve to enhance the understanding and treatment of inflammatory diseases and allergies, showcasing the impact of dedicated inventors in the realm of healthcare.